Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Mechanism of antiasthmatic action of inhaled furosemide investigated

May 23, 1997

Pharmacological profile of selective, orally active PDE IV inhibitor

May 23, 1997

Orally active HNE inhibitors from Cortech effective in lung injury model

May 23, 1997

Celgene describes TNF/PDE inhibitors

May 22, 1997

Pranlukast evaluated in numerous preclinical and clinical studies

May 21, 1997

Chiroscience starts clinical development of PDE IV inhibitor

May 21, 1997

Leukotriene biosynthesis inhibitors from Abbott

May 21, 1997

Preclinical and clinical results reported for RP-73401

May 20, 1997

Suplatast shows antiinflammatory effects in mild asthma

May 20, 1997

Zileuton associated with antiinflammatory effects in subgroup of asthmatics

May 20, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...